For example, the pseudogene PTENP1 that highly homologous to the tumor suppressor gene PTEN was found to increase cellular levels of PTEN mRNA in prostate cancer through competitively binding to miR-17, miR-19, miR-21, miR-26 and miR-214 families. This evidence concerns the gene PTEN and prostate cancer.